annual EBITDA:
$141.84M+$18.15M(+14.68%)Summary
- As of today (May 29, 2025), ASTH annual EBITDA is $141.84 million, with the most recent change of +$18.15 million (+14.68%) on December 31, 2024.
- During the last 3 years, ASTH annual EBITDA has risen by +$41.18 million (+40.91%).
- ASTH annual EBITDA is now at all-time high.
Performance
ASTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$23.76M+$9.46M(+66.16%)Summary
- As of today (May 29, 2025), ASTH quarterly EBITDA is $23.76 million, with the most recent change of +$9.46 million (+66.16%) on March 31, 2025.
- Over the past year, ASTH quarterly EBITDA has dropped by -$12.92 million (-35.23%).
- ASTH quarterly EBITDA is now -80.23% below its all-time high of $120.16 million, reached on June 1, 2020.
Performance
ASTH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$128.92M-$12.92M(-9.11%)Summary
- As of today (May 29, 2025), ASTH TTM EBITDA is $128.92 million, with the most recent change of -$12.92 million (-9.11%) on March 31, 2025.
- Over the past year, ASTH TTM EBITDA has dropped by -$4.49 million (-3.36%).
- ASTH TTM EBITDA is now -29.90% below its all-time high of $183.90 million, reached on September 1, 2020.
Performance
ASTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ASTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | -35.2% | -3.4% |
| 3 y3 years | +40.9% | +0.2% | +32.3% |
| 5 y5 years | +190.3% | +95.5% | +114.0% |
ASTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.9% | -51.0% | +111.3% | -9.2% | +333.9% |
| 5 y | 5-year | at high | +376.9% | -80.2% | +116.3% | -29.9% | +556.3% |
| alltime | all time | at high | +1872.8% | -80.2% | +116.3% | -29.9% | +556.3% |
ASTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $23.76M(+66.2%) | $128.92M(-9.1%) |
| Dec 2024 | $141.84M(+14.7%) | $14.30M(-66.7%) | $141.84M(+2.2%) |
| Sep 2024 | - | $42.93M(-10.4%) | $138.79M(-2.2%) |
| Jun 2024 | - | $47.92M(+30.6%) | $141.96M(+6.4%) |
| Mar 2024 | - | $36.69M(+226.1%) | $133.40M(+7.9%) |
| Dec 2023 | $123.69M(+10.4%) | $11.25M(-75.6%) | $123.69M(-4.5%) |
| Sep 2023 | - | $46.10M(+17.1%) | $129.53M(-1.8%) |
| Jun 2023 | - | $39.37M(+46.0%) | $131.87M(+14.3%) |
| Mar 2023 | - | $26.97M(+57.8%) | $115.33M(+2.9%) |
| Dec 2022 | $112.08M(+11.3%) | - | - |
| Dec 2022 | - | $17.09M(-64.7%) | $112.08M(+43.7%) |
| Sep 2022 | - | $48.44M(+112.1%) | $78.02M(+162.6%) |
| Jun 2022 | - | $22.83M(-3.7%) | $29.71M(-69.5%) |
| Mar 2022 | - | $23.71M(-239.8%) | $97.42M(-3.2%) |
| Dec 2021 | $100.66M(+238.4%) | -$16.97M(<-9900.0%) | $100.66M(-456.2%) |
| Sep 2021 | - | $133.00K(-99.9%) | -$28.26M(-289.3%) |
| Jun 2021 | - | $90.54M(+235.9%) | $14.93M(-66.5%) |
| Mar 2021 | - | $26.95M(-118.5%) | $44.55M(+49.8%) |
| Dec 2020 | $29.74M(-39.1%) | -$145.88M(-436.8%) | $29.74M(-83.8%) |
| Sep 2020 | - | $43.31M(-64.0%) | $183.90M(+14.4%) |
| Jun 2020 | - | $120.16M(+888.8%) | $160.76M(+166.9%) |
| Mar 2020 | - | $12.15M(+46.9%) | $60.23M(+23.3%) |
| Dec 2019 | $48.85M(-52.3%) | $8.27M(-59.0%) | $48.85M(+15.4%) |
| Sep 2019 | - | $20.17M(+2.7%) | $42.33M(-47.3%) |
| Jun 2019 | - | $19.64M(+2447.2%) | $80.39M(+6.9%) |
| Mar 2019 | - | $771.00K(-55.9%) | $75.17M(-26.7%) |
| Dec 2018 | $102.49M(+48.8%) | $1.75M(-97.0%) | $102.49M(+1.7%) |
| Sep 2018 | - | $58.23M(+303.9%) | $100.74M(+161.0%) |
| Jun 2018 | - | $14.42M(-48.7%) | $38.60M(+86.8%) |
| Mar 2018 | - | $28.09M(-819.4%) | $20.67M(-257.0%) |
| Dec 2017 | $68.87M(-960.7%) | - | - |
| Sep 2017 | - | -$3.90M(+11.1%) | -$13.16M(+22.5%) |
| Jun 2017 | - | -$3.51M(-22.2%) | -$10.74M(+34.3%) |
| Mar 2017 | -$8.00M(+8.8%) | -$4.52M(+268.6%) | -$8.00M(+6.2%) |
| Dec 2016 | - | -$1.23M(-17.3%) | -$7.54M(-0.3%) |
| Sep 2016 | - | -$1.48M(+91.6%) | -$7.56M(+17.9%) |
| Jun 2016 | - | -$773.60K(-80.9%) | -$6.41M(-14.5%) |
| Mar 2016 | -$7.35M(-1642.0%) | -$4.05M(+224.2%) | -$7.50M(+146.8%) |
| Dec 2015 | - | -$1.25M(+274.9%) | -$3.04M(+14.5%) |
| Sep 2015 | - | -$333.50K(-82.1%) | -$2.65M(+1415.7%) |
| Jun 2015 | - | -$1.86M(-559.2%) | -$175.10K(-136.7%) |
| Mar 2015 | $476.70K | $404.80K(-146.7%) | $476.60K(+563.8%) |
| Dec 2014 | - | -$866.40K(-140.4%) | $71.80K(-320.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $2.15M(-277.7%) | -$32.60K(-98.9%) |
| Jun 2014 | - | -$1.21M(+24.4%) | -$2.98M(-22.3%) |
| Jan 2014 | -$3.83M(-51.8%) | -$970.80K(+21.7%) | -$3.83M(+12.1%) |
| Oct 2013 | - | -$797.50K(-41.1%) | -$3.41M(-52.0%) |
| Jul 2013 | - | -$1.35M(+92.0%) | -$7.11M(-18.5%) |
| Apr 2013 | - | -$705.60K(+26.7%) | -$8.73M(+9.8%) |
| Jan 2013 | -$7.95M(+1897.7%) | -$556.90K(-87.6%) | -$7.95M(+3.8%) |
| Oct 2012 | - | -$4.50M(+51.2%) | -$7.66M(+152.5%) |
| Jul 2012 | - | -$2.97M(-4036.7%) | -$3.03M(+2064.9%) |
| Apr 2012 | - | $75.50K(-128.3%) | -$140.10K(-64.9%) |
| Jan 2012 | -$397.90K(+2226.9%) | -$266.50K(-304.7%) | -$398.70K(+162.3%) |
| Oct 2011 | - | $130.20K(-264.2%) | -$152.00K(-47.3%) |
| Jul 2011 | - | -$79.30K(-56.7%) | -$288.30K(+22.8%) |
| Apr 2011 | - | -$183.10K(+824.7%) | -$234.70K(+1272.5%) |
| Jan 2011 | -$17.10K(-83.9%) | -$19.80K(+224.6%) | -$17.10K(-83.9%) |
| Oct 2010 | - | -$6100.00(-76.3%) | -$106.20K(+36.3%) |
| Jul 2010 | - | -$25.70K(-174.5%) | -$77.90K(-512.2%) |
| Apr 2010 | - | $34.50K(-131.7%) | $18.90K(-117.7%) |
| Jan 2010 | -$106.40K(-87.0%) | -$108.90K(-590.5%) | -$106.50K(+38.1%) |
| Oct 2009 | - | $22.20K(-68.8%) | -$77.10K(-81.2%) |
| Jul 2009 | - | $71.10K(-178.2%) | -$410.50K(-49.8%) |
| Apr 2009 | - | -$90.90K(+14.3%) | -$818.40K(+1.2%) |
| Jan 2009 | -$816.00K(+2123.4%) | -$79.50K(-74.5%) | -$808.50K(+9.4%) |
| Oct 2008 | - | -$311.20K(-7.6%) | -$738.90K(+70.3%) |
| Jul 2008 | - | -$336.80K(+360.7%) | -$433.80K(+177.4%) |
| Apr 2008 | - | -$73.10K(+825.3%) | -$156.40K(+87.8%) |
| Mar 2008 | - | -$7900.00(-20.2%) | -$83.30K(-4.4%) |
| Dec 2007 | -$36.70K(+33.5%) | -$9900.00(+62.3%) | -$87.10K(+2.2%) |
| Sep 2007 | - | -$6100.00(-89.7%) | -$85.20K(-1.3%) |
| Jun 2007 | - | -$59.40K(+407.7%) | -$86.30K(+150.9%) |
| Mar 2007 | - | -$11.70K(+46.3%) | -$34.40K(+25.1%) |
| Dec 2006 | -$27.50K(+106.8%) | -$8000.00(+11.1%) | -$27.50K(+20.6%) |
| Sep 2006 | - | -$7200.00(-4.0%) | -$22.80K(+14.6%) |
| Jun 2006 | - | -$7500.00(+56.3%) | -$19.90K(+31.8%) |
| Mar 2006 | - | -$4800.00(+45.5%) | -$15.10K(+12.7%) |
| Dec 2005 | -$13.30K(+31.7%) | -$3300.00(-23.3%) | -$13.40K(+20.7%) |
| Sep 2005 | - | -$4300.00(+59.3%) | -$11.10K(+23.3%) |
| Jun 2005 | - | -$2700.00(-12.9%) | -$9000.00(-19.6%) |
| Mar 2005 | - | -$3100.00(+210.0%) | -$11.20K(+9.8%) |
| Dec 2004 | -$10.10K(+29.5%) | -$1000.00(-54.5%) | -$10.20K(+10.9%) |
| Sep 2004 | - | -$2200.00(-55.1%) | -$9200.00(+31.4%) |
| Jun 2004 | - | -$4900.00(+133.3%) | -$7000.00(+233.3%) |
| Mar 2004 | - | -$2100.00 | -$2100.00 |
| Dec 2003 | -$7800.00 | - | - |
FAQ
- What is Astrana Health annual EBITDA?
- What is the all time high annual EBITDA for Astrana Health?
- What is Astrana Health annual EBITDA year-on-year change?
- What is Astrana Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Astrana Health?
- What is Astrana Health quarterly EBITDA year-on-year change?
- What is Astrana Health TTM EBITDA?
- What is the all time high TTM EBITDA for Astrana Health?
- What is Astrana Health TTM EBITDA year-on-year change?
What is Astrana Health annual EBITDA?
The current annual EBITDA of ASTH is $141.84M
What is the all time high annual EBITDA for Astrana Health?
Astrana Health all-time high annual EBITDA is $141.84M
What is Astrana Health annual EBITDA year-on-year change?
Over the past year, ASTH annual EBITDA has changed by +$18.15M (+14.68%)
What is Astrana Health quarterly EBITDA?
The current quarterly EBITDA of ASTH is $23.76M
What is the all time high quarterly EBITDA for Astrana Health?
Astrana Health all-time high quarterly EBITDA is $120.16M
What is Astrana Health quarterly EBITDA year-on-year change?
Over the past year, ASTH quarterly EBITDA has changed by -$12.92M (-35.23%)
What is Astrana Health TTM EBITDA?
The current TTM EBITDA of ASTH is $128.92M
What is the all time high TTM EBITDA for Astrana Health?
Astrana Health all-time high TTM EBITDA is $183.90M
What is Astrana Health TTM EBITDA year-on-year change?
Over the past year, ASTH TTM EBITDA has changed by -$4.49M (-3.36%)